Atypical hearing loss in women with breast cancer receiving adjuvant treatment

Breast

Volumn 15, Issue 3, 2006, Pages 447-450

  Jenkins, V ^a   Beveridge, H ^a   Low, R ^b   Mitra, S ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

Atypical hearing loss; Breast cancer; Chemotherapy; Endocrine therapy

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; ESTROGEN; FLUOROURACIL; LETROZOLE; TAMOXIFEN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEARING ACUITY; HEARING LOSS; HUMAN; OTOTOXICITY; PRIORITY JOURNAL; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PILOT STUDY; PURE TONE AUDIOMETRY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUDIOMETRY, PURE-TONE; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HEARING LOSS; HUMANS; MIDDLE AGED; PILOT PROJECTS;

EID: 33744525843     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.06.005     Document Type: Article

References (10)

1. Strachan D. Sudden sensorineural deafness and hormone replacement therapy. J Laryngol Otol 110 12 (1996) 1148-1150
2. Stenberg A.E., Wang H., Fish III J., Schrott-Fischer A., Sahlin L., and Hultcrantz M. Estrogen receptors in the normal adult and developing human inner ear and in Turner's syndrome. Hear Res 157 1-2 (2001) 87-92
3. Hultcrantz E., Stenquist M., and Lyttkens L. Sudden deafness: a retrospective evaluation of dextran therapy. ORL J Otorhinolaryngol Relat Spec 56 3 (1994) 137-142
4. Hallmark R.J., et al. Factors influencing ototoxicity in ovarian cancer patients treated with Cis-platinum based chemotherapy. Eur J Gynaecol Oncol 13 1 (1992) 35-44
5. Strumberg D., et al. Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol 13 2 (2002) 229-236
6. Tibaldi C., et al. A case of ototoxicity in a patient with metastatic carcinoma of the breast treated with paclitaxel and vinorelbine. Eur J Cancer 34 7 (1998) 1133-1134
7. ISO-7029. Acoustics-statistical distribution of hearing thresholds as a function of age (2000), International Organization for Standardization, Geneva
8. Kim S.H., et al. The association between serum estradiol level and hearing sensitivity in postmenopausal women. Obstet Gynecol 99 5 Pt 1 (2002) 726-730
9. Wharton J.A., and Church G.T. Influence of menopause on the auditory brainstem response. Audiology 29 4 (1990) 196-201
10. Wefel J.S., Kayl A.E., and Meyers C.A. Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br J Cancer 90 9 (2004) 1691-1696